Radiosurgery for Spasticity
(SPASM Trial)
Trial Summary
What is the purpose of this trial?
A scientific study is being done to test a special treatment for people who have spasticity or tight muscles. This treatment is called "stereotactic radiosurgery dorsal rhizotomy." It uses very accurate beams of radiation to target certain nerves in the back to help loosen up the muscles. In this study, people are put into two groups by chance: one group gets the real treatment, and the other group gets a "fake" treatment that doesn't do anything. This fake treatment is called a "sham." Doing this helps make sure the study is fair and the results are true. After the people in the study get their treatment, the researchers will watch and see how they do. They will check if their muscles are less stiff and if they have any side effects. By looking at the results from both groups, the researchers can find out if the special treatment really helps people with spasticity. Patients who got the "fake" treatment will be eligible to receive the "real" treatment after 6 months.
Will I have to stop taking my current medications?
The trial protocol does not specify whether you need to stop taking your current medications. However, since the trial is for people whose spasticity is not helped by their current medications, you might be able to continue them. It's best to ask the trial organizers for more details.
What data supports the effectiveness of the treatment Radiosurgery for Spasticity?
Is selective dorsal rhizotomy generally safe for treating spasticity?
Selective dorsal rhizotomy (SDR) is generally considered safe for reducing spasticity, with low complication rates reported in both children and adults. While spinal cord tethering has not been reported as a complication, the procedure is well tolerated with minimal risk of progressive lumbar instability.24678
How is the treatment Stereotactic Radiosurgery Dorsal Rhizotomy different from other treatments for spasticity?
Stereotactic Radiosurgery Dorsal Rhizotomy is unique because it uses precise radiation to target specific nerve roots in the spine, unlike traditional surgical methods that involve cutting nerves. This non-invasive approach may offer a novel option for reducing spasticity without the need for open surgery.1491011
Research Team
Evan Thomas, MD/PhD
Principal Investigator
Ohio State University
Eligibility Criteria
This trial is for individuals over 16 years old with chronic spasticity from conditions like stroke, SCI, or cerebral palsy that doesn't improve with medication. If under 18, parental consent is needed. It's not for those who can't lie on their back for the procedure, if the target nerve isn't visible on scans, or if pregnant.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either stereotactic radiosurgery dorsal rhizotomy or a sham treatment
Follow-up
Participants are monitored for changes in spasticity and quality of life
Crossover Treatment
Participants who received the sham treatment are eligible to receive the real treatment
Long-term Follow-up
Participants are monitored for long-term changes in spasticity-related quality of life
Treatment Details
Interventions
- Sham (Other)
- Stereotactic Radiosurgery Dorsal Rhizotomy (Radiation)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Ohio State University
Lead Sponsor
Dr. John J. Warner
Ohio State University
Chief Executive Officer since 2023
MD, MBA
Dr. Peter Mohler
Ohio State University
Chief Medical Officer since 2023
PhD in Molecular Biology
Centro Diagnostico Milano, Co-PI: Pantaleo Romanelli, MD
Collaborator
Varian Medical Systems
Industry Sponsor
Dow R. Wilson
Varian Medical Systems
Chief Executive Officer since 2012
MBA from Dartmouth's Amos Tuck School of Business, BA from Brigham Young University
Dr. Deepak Khuntia
Varian Medical Systems
Chief Medical Officer since 2020
MD from the University of Cambridge, PhD from the University of Leicester